Evidence map›Paper›PMID 31250048›Full record

ArticleInflammation research : official journal of the European Histamine Research Society ... [et al.]2019

Inhibition of JAK2/STAT3 signaling pathway protects mice from the DDP-induced acute kidney injury in lung cancer.

Lei Zhang, Peng Lu, Xu Guo, Ting Liu, Xu Luo, Yi-Tang Zhu

Abstract read
PubMed Publisher
In one paragraph

Article in Inflammation research : official journal of the European Histamine Research Society ... [et al.], 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
2.0field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 32 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Lei ZhangDepartment of Clinical Laboratory, Cangzhou Central Hospital, No. 16, Xinhua Western Road, Cangzhou, 3061001, Hebei, China.
Peng LuDepartment of Clinical Laboratory, Cangzhou Central Hospital, No. 16, Xinhua Western Road, Cangzhou, 3061001, Hebei, China.
Xu GuoDepartment of Clinical Laboratory, the 252nd Hospital of PLA, Baoding, China.
Ting LiuDepartment of Clinical Laboratory, the 252nd Hospital of PLA, Baoding, China.
Xu LuoDepartment of Pharmacy, Cangzhou Central Hospital, Cangzhou, China.
Yi-Tang ZhuDepartment of Clinical Laboratory, Cangzhou Central Hospital, No. 16, Xinhua Western Road, Cangzhou, 3061001, Hebei, China. zhu_yitang9@126.com.
Cangzhou Central Hospital · CNBaoding People's Hospital · CN

Funding

Cangzhou Science and Technology R&D Instruction Project No. 183302086
6 · The paper itself

Abstract

objectiveTo explore AG490 (the inhibitor of Janus kinase (JAK) 2/signal transducer and activator of transcription (STAT) 3 pathway) in cisplatin (DDP)-induced acute kidney injury (AKI) in mice with lung cancer.

methodsMice were randomly divided into normal, model, AG490, DDP and DDP + AG490 groups. The lung cancer models were established except for Normal group. The levels of blood urea nitrogen (BUN) and creatinine and the status of oxidative stress were detected. Then, histological changes were assessed by HE and PAS staining and apoptosis by TUNEL experiment. The molecule expressions were detected by qRT-PCR and western blot, and immunohistochemistry, respectively.

resultsDDP inhibited the tumor growth in mice with lung cancer, which was further promoted by the combination with AG490. Mice in the DDP group had elevated levels of BUN and creatinine than those in the Normal group with the increased inflammatory cytokines (TNF-α, IL-6, MCP-1 and CXCL-1) and malondialdehyde (MDA) level and the decreased glutathione (GSH), superoxide dismutase (SOD) and catalase (CAT). In addition, DDP could activate the JAK2/STAT3 pathway to promote the apoptosis by upregulating Bax, cleaved caspase-9 and cleaved caspase-3 while downregulating the Bcl-2 in the kidney tissues. DDP + AG490 group showed the alleviated AKI and the improvements in oxidative stress, inflammatory responses and apoptosis in the kidney tissues, as compared to DDP group.

conclusionAG490 alleviated DDP-induced AKI in lung cancer mice with improved oxidative stress and inflammation, and the suppression of JAK2/STAT3 pathway.

Indexed as

Acute Kidney InjuryAnimalsApoptosisBlood Urea NitrogenCarcinoma, Lewis LungCisplatinCreatinineFemaleInflammationJanus Kinase 2Lung NeoplasmsMaleMiceMice, Inbred C57BLOxidative StressSignal Transductionalpha-cyano-(3,4-dihydroxy)-N-benzylcinnamideCisplatinCreatinineJak2 protein, mouseJanus Kinase 2Stat3 protein, mouseSTAT3 Transcription FactorTyrphostinsAcute kidney injuryCisplatinJAK2/STAT3Lung cancer

Identifiers

PMID31250048
OpenAlexW2993006572

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.